EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic biomarker for type 2 diabetic peripheral neuropathy via comprehensive bioinformatics analysis

Xiaoyu Chen, Qingquan Liu, Niyao Chen, Jiangxin Ma, Xiaohong Wu, Haibin Zhang, Liying Yu iD, Huibin Huang

Journal of Diabetes · 2024

DOI: 10.1111/1753-0407.13506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes, 2024. Verfasst von Xiaoyu Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Neuropathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Provincial Health and Health Scientific Research Talent Training, Fujian Quanzhou Science and Technology Plan, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic peripheral neuropathy (DPN) is a common complication of Type 2 diabetes mellitus (T2DM), which frequently results in disabling neuropathic pain and lower‐limb amputation. The identification of noninvasive biomarkers for DPN may help early detection and individualized treatment of DPN.

Methods

In this study, we identified differentially expressed genes (DEGs) between DPN and the control based on blood‐source (GSE95849) and tissue‐source gene expression profiles (GSE143979) from the Gene Expression Omnibus (GEO) database using limma, edgeR, and DESeq2 approaches. KEGGG and GO functional enrichments were performed. Hub genes and their correlation with infiltrating immune cells were analyzed. Real‐time quantitative polymerase chain reaction (RT‐qPCR) was used to quantify hub gene expression.

Results

In total, 144 DEGs between DPN and the control were identified. Functional enrichment revealed that the DEGs were mainly enriched in immune‐related pathways like the Fc epsilon receptor Ig signaling pathway. By protein–protein interaction (PPI) network analysis, FCER1G , SYK , ITGA4 , F13A1 , MS4A2 , and PTK2B were screened as hub genes with higher expression in DPN patients, among which half were immune genes ( FCER1G , PTK2B , and SYK ). RT‐qPCR demonstrated that mRNA expression of FCER1G , PTK2B , and SYK was significantly increased in patients with DPN compared with both diabetic nonperipheral neuropathy (DNN) and normal subjects. The area under the receiver operating characteristic (ROC) curve of FCER1G , PTK2B , and SYK was 0.84, 0.81, and 0.73, respectively, suggesting their great advantages as diagnostic biomarkers to predict the progression of neuropathy in T2DM. Further analysis indicated that the expression of FCER1G , PTK2B , and SYK was negatively correlated with the cell proportion of significantly altered resting natural killer cells, T follicular helper cells, and activated mast cells, but positively correlated with monocytes.

Conclusions

Our findings demonstrated FCER1G , PTK2B , and SYK are potential diagnostic biomarkers and therapeutic targets for DPN, which provides new insight into DPN pathogenesis and therapies. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetic NeuropathiesHumansAmputation, SurgicalComputational BiologyDatabases, Factual

Stichwörter der Autor:innen

Type 2 diabetesbioinformatic analysisimmune geneimmune infiltrationperipheral neuropathy

Autor:innen und Institutionen

  • Department of Endocrinology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
  • Department of Cardiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
  • Central Laboratory, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.

ORCID-Profile: Liying Yu

Förderung

  • Fujian Provincial Health and Health Scientific Research Talent Training
  • Fujian Quanzhou Science and Technology Plan
  • Natural Science Foundation of Fujian Province
  • the doctoral research project of Second Affiliated Hospital of Fujian Medical University

Zitieren

APA

Chen, X., Liu, Q., Chen, N., Ma, J., Wu, X., Zhang, H., Yu, L., & Huang, H. (2024). Diagnostic biomarker for type 2 diabetic peripheral neuropathy via comprehensive bioinformatics analysis. Journal of Diabetes. https://doi.org/10.1111/1753-0407.13506

Vancouver

Chen X, Liu Q, Chen N, Ma J, Wu X, Zhang H, et al. Diagnostic biomarker for type 2 diabetic peripheral neuropathy via comprehensive bioinformatics analysis. Journal of Diabetes. 2024. doi:10.1111/1753-0407.13506

BibTeX
@article{Chen2024,
  author = {Chen, Xiaoyu and Liu, Qingquan and Chen, Niyao and Ma, Jiangxin and Wu, Xiaohong and Zhang, Haibin and Yu, Liying and Huang, Huibin},
  title = {Diagnostic biomarker for type 2 diabetic peripheral neuropathy via comprehensive bioinformatics analysis},
  journal = {Journal of Diabetes},
  year = {2024},
  doi = {10.1111/1753-0407.13506}
}
Kostenlos starten →